Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation.
Pancreatic cancer has an enrichment of stem-like cancer cells (CSCs) that contribute to chemoresistant tumors prone to metastasis and recurrence. Drug screening assays based on cytotoxicity cannot identify specific CSC inhibitors, because CSCs comprise only a small portion of cancer cell population,...
Main Authors: | Kishore Polireddy, Ruochen Dong, Peter R McDonald, Tao Wang, Brendan Luke, Ping Chen, Melinda Broward, Anuradha Roy, Qi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5072586?pdf=render |
Similar Items
-
Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
by: Thomas Wirth, et al.
Published: (2010-12-01) -
Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma
by: Carla Cano, et al.
Published: (2010-01-01) -
Searching for the Binding Partners for the Novel PHKG1 Variant γ 181
by: Polireddy, Kishore
Published: (2009) -
Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells
by: Li H, et al.
Published: (2020-04-01) -
Regulators of epithelial mesenchymal transition in pancreatic cancer
by: Shin eHamada, et al.
Published: (2012-07-01)